Anthony Meager
#166,573
Most Influential Person Now
Anthony Meager's AcademicInfluence.com Rankings
Anthony Meagerphilosophy Degrees
Philosophy
#9831
World Rank
#13445
Historical Rank
Logic
#6790
World Rank
#8339
Historical Rank

Anthony Meagerbiology Degrees
Biology
#13524
World Rank
#17073
Historical Rank
Immunology
#938
World Rank
#962
Historical Rank

Download Badge
Philosophy Biology
Anthony Meager's Degrees
- Doctorate Medicine Stanford University
Why Is Anthony Meager Influential?
(Suggest an Edit or Addition)Anthony Meager's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines (2010) (551)
- Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. (1992) (459)
- Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1 (2006) (360)
- Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. (1991) (333)
- IMMUNOREACTIVE α-INTERFERON IN INSULIN-SECRETING β CELLS IN TYPE 1 DIABETES MELLITUS (1987) (330)
- TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES (1988) (283)
- ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILURE (1988) (274)
- Biological activity of interleukins-28 and -29: comparison with type I interferons. (2005) (234)
- Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients (1988) (231)
- Cytokine regulation of cellular adhesion molecule expression in inflammation. (1999) (227)
- Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. (1989) (204)
- Assays for tumour necrosis factor and related cytokines. (1989) (203)
- Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. (2007) (203)
- Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. (1988) (197)
- TUMOUR NECROSIS FACTOR IN BRONCHOPULMONARY SECRETIONS OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROME (1989) (196)
- Cytokines in proliferative vitreoretinopathy (1991) (191)
- Anti‐cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon‐alpha, interferon‐omega and interleukin‐12 in patients with thymoma and/or myasthenia gravis (2003) (161)
- Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity (1989) (149)
- Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. (1989) (147)
- Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. (2008) (143)
- Cytokines in skin lesions of psoriasis. (1990) (137)
- Biological assays for interferons. (2002) (137)
- Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. (1990) (136)
- High levels of interferon alpha in the sera of children with dengue virus infection. (1993) (133)
- TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. (1993) (129)
- Association of innate immune activation with latent Epstein-Barr virus in active MS lesions (2012) (127)
- Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. (2012) (125)
- Aire-Deficient C57BL/6 Mice Mimicking the Common Human 13-Base Pair Deletion Mutation Present with Only a Mild Autoimmune Phenotype1 (2009) (121)
- Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS‐1) (2007) (119)
- In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation. (1989) (118)
- Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: Clinical and pathogenetic implications (2011) (115)
- Effect of cyclo‐oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide‐induced neutrophil infiltration in mouse lung (1996) (109)
- Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. (1990) (107)
- INTERFERON INDUCTION AND INCREASED NATURAL KILLER-CELL ACTIVITY IN INFLUENZA INFECTIONS IN MAN (1981) (100)
- Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes (2008) (100)
- Clonal analysis of functionally distinct human CD4+ T cell subsets (1988) (97)
- Immunohistochemical Localization of Interferons in Human Placental Tissues in Normal, Ectopic, and Molar Pregnancy (1990) (94)
- Spontaneous production of tumour necrosis factor α and interleukin-1β during interferon-α treatment of chronic HBV infection (1990) (93)
- Cutting Edge: TRANK, a Novel Cytokine That Activates NF-κB and c-Jun N-Terminal Kinase (1998) (88)
- Spontaneous neutralising antibodies to interferon-a and interleukin-12 in thymoma-associated autoimmune disease (1997) (85)
- Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor‐alpha production in Pneumocystis carinii pneumonia (1990) (83)
- Cytokines in sera from insulin‐dependent diabetic patients at diagnosis (1991) (81)
- Aicardi-Goutières syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21. (2000) (79)
- Cytokine inter-relationships and their association with disease activity in arthritis. (1992) (75)
- The role of tumour necrosis factor‐alpha and IL‐1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis (1994) (73)
- Assays for transforming growth factor β (1991) (72)
- Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor, and soluble TNF receptor. (1995) (72)
- Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus (1981) (72)
- Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV‐infected individuals (1991) (70)
- Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. (2008) (70)
- Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor. (2003) (69)
- Autoimmunizing Mechanisms in Thymoma and Thymus * (2008) (68)
- Scenarios for Autoimmunization of T and B Cells in Myasthenia Gravis (2003) (67)
- Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection (1990) (63)
- Anti-Cytokine Autoantibodies Preceding Onset of Autoimmune Polyendocrine Syndrome Type I Features in Early Childhood (2013) (59)
- Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum (1990) (58)
- Passive immunization against tumour necrosis factor‐alpha (TNF‐α) and IL‐lβ protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats (1992) (58)
- Phenotypic and functional analysis of human CD3- decidual leucocyte clones. (1990) (55)
- Human NK cells constitutively express membrane TNF‐α (mTNFα) and present mTNFα‐dependent cytotoxic activity (1999) (55)
- Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF). (1987) (54)
- Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection. (1996) (54)
- Measurement of cytokines by bioassays: theory and application. (2006) (54)
- Localization of α-interferon in the human feto-placental unit (1988) (53)
- Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia. (1989) (51)
- Neutralizing antibodies to granulocyte–macrophage colony‐stimulating factor, interleukin‐1α and interferon‐α but not other cytokines in human immunoglobulin preparations (2000) (51)
- Application of an immortalized human endothelial cell line to the leucocyte:endothelial adherence assay. (1993) (51)
- Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG. (1997) (50)
- Anti‐cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice (2013) (49)
- The interferons : characterization and application (2006) (48)
- TRANK, a novel cytokine that activates NF-kappa B and c-Jun N-terminal kinase. (1998) (47)
- Lipopolysaccharide, tumor necrosis factor, and interleukin-1 interact to cause hypotension. (1992) (45)
- Clinical and Serologic Parallels to APS-I in Patients with Thymomas and Autoantigen Transcripts in Their Tumors (2014) (44)
- DETECTION OF PYROGEN BY CYTOKINE RELEASE (1988) (43)
- Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection. (1990) (42)
- Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega. (2001) (42)
- AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I (2008) (41)
- Production of interferon-gamma and tumour necrosis factor-alpha by human T-cell clones expressing different forms of the gamma delta receptor. (1990) (41)
- Human interferon alpha and gamma production by lymphocytes during the generation of influenza virus-specific cytotoxic T lymphocytes. (1986) (40)
- Human NK cells constitutively express membrane TNF-alpha (mTNFalpha) and present mTNFalpha-dependent cytotoxic activity. (1999) (39)
- Induction of interferon alpha and gamma from human lymphocytes by dengue virus-infected cells. (1986) (39)
- Assay of pyrogenic contamination in pharmaceuticals by cytokine release from monocytes. (1988) (38)
- Modulation of antibody-mediated glomerular injury in vivo by interleukin-6. (1993) (36)
- An assessment of biological potency and molecular characteristics of different innovator and noninnovator interferon-beta products. (2011) (36)
- Effects of macrophage‐colony stimulating factor on human monocytes: Induction of expression of urokinase‐type plasminogen activator, but not of secreted prostaglandin E2, interleukin‐6, interleukin‐1, or tumor necrosis factor‐a (1993) (36)
- Production of tumor necrosis factor-alpha by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease. (1991) (35)
- Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease. (2008) (35)
- Involvement of a gene on chromosome 9 in human fibroblast Interferon production (1979) (35)
- A cytotoxicity assay for tumour necrosis using a human rhabdomyosarcoma cell line (1991) (34)
- Detection of hybridomas secreting monoclonal antibodies to human gamma interferon using a rapid screening technique and specificity of certain monoclonal antibodies to gamma interferon. (1984) (32)
- Transforming growth factor‐β induced by live or ultraviolet‐inactivated equid herpes virus type‐1 mediates immunosuppression in the horse (1997) (32)
- Characterization of interferon messenger RNA from human lymphoblastoid cells. (1979) (32)
- Effect of IFNβ and anti-IFNβ antibodies on NK cells in multiple sclerosis patients (2000) (32)
- Hepatic interferon‐α gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection (1991) (32)
- Gene Therapy Technologies, Applications and Regulations (1999) (31)
- Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats. (1992) (30)
- IL-2- and IFN gamma-enhanced natural cytotoxic activity: analysis of the role of different lymphoid subsets and implications for activation routes. (1986) (30)
- Suppression of lymphokine‐activated killer (LAK) cell induction mediated by interleukin‐4 and transforming growth factor‐β1: effect of addition of exogenous tumour necrosis factor‐alpha and interferon‐gamma, and measurement of their endogenous production (1990) (29)
- Enhancement of interferon mRNA levels in butyric acid‐treated namalwa cells (1980) (29)
- Assays for measuring soluble cellular adhesion molecules and soluble cytokine receptors. (1996) (29)
- Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2. (1989) (28)
- Continuous delivery of human type I interferons (α/β) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model (2007) (28)
- Virus RNA and protein synthesis in cells infected with different strains of Newcastle disease virus. (1971) (28)
- Factors Involved in the Production of Interferon by Inactivated Newcastle Disease Virus (1972) (28)
- Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta. (2005) (28)
- Hypothetical review: thymic aberrations and type‐I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes (2008) (27)
- T cell activation in vivo by dengue virus infection. (1995) (27)
- Reduction of tumor necrosis factor alpha and interleukin-1 beta levels in human synovial tissue by interleukin-4 and glucocorticoid. (1993) (26)
- Spontaneous and interleukin 2 induced secretion of tumour necrosis factor and gamma interferon following autologous marrow transplantation or chemotherapy (1989) (26)
- Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-γ responses of healthy CD4+ T cells (2003) (25)
- Somatic cell genetics of human interferon production in human-rodent cell hybrids. (1979) (24)
- Production of Interferon by Ultraviolet Radiation Inactivated Newcastle Disease Virus (1972) (23)
- Influenza virus-specific T cells lead to early interferon gamma in lungs of infected hosts: development of a sensitive radioimmunoassay. (1989) (23)
- Measurement of neutralising antibodies to type I interferons by gene expression assays specific for type 1 interferon-inducible 6-16 mRNA. (2009) (23)
- The molecular biology of cytokines (1998) (23)
- Reduction of tumor necrosis factor α and interleukin-1β levels in human synovial tissue by interleukin-4 and glucocorticoid (1992) (22)
- Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus. (1990) (22)
- What mediates the immunopathological component of the immune response to Mycobacterium tuberculosis? Can it be switched off? (1990) (22)
- Interferons Alpha, Beta, and Omega (1998) (21)
- A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha. (1984) (21)
- Expanded TCR Vβ subsets of CD8+ T-cells in late-onset myasthenia gravis: Novel parallels with thymoma patients (2009) (20)
- The preparation of interferon gamma-producing T-cell hybridomas from jacalin-stimulated T lymphocytes and the SH9 T-cell line. (1984) (20)
- Thymus, Thymoma, and Specific T Cells in Myasthenia Gravis a (1998) (20)
- Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit. (1986) (20)
- Production of interferon and tumour necrosis factor by cloned human natural cytotoxic lymphocytes and T cells. (1987) (20)
- Continuous delivery of human type I interferons (alpha/beta) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model. (2007) (19)
- Tumor necrosis factor mediates the protective effect of Freund's adjuvant against autoimmune diabetes in BB rats. (1995) (19)
- The Effect of HLA and Insulin‐Dependent Diabetes Mellitus on the Secretion Levels of Tumour Necrosis Factors Alpha and Beta and Gamma Interferon (1990) (19)
- Assays for antiviral activity. (2004) (19)
- Measuring Autoantibodies against IL‐17F and IL‐22 in Autoimmune Polyendocrine Syndrome Type I by Radioligand Binding Assay Using Fusion Proteins (2011) (19)
- Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations. (2000) (18)
- TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cells. (1994) (18)
- Radioligand-Binding Assay Reveals Distinct Autoantibody Preferences for Type I Interferons in APS I and Myasthenia Gravis Subgroups (2012) (18)
- Evaluation of assay designs for assays using microtitre plates: results of a study of in vitro bioassays and immunoassays for tumour necrosis factor (TNF). (1995) (18)
- Expression of intercellular adhesion molecule-1 (ICAM-1) on human thyroid cell lines correlated with their binding of lymphoblasts (1990) (18)
- Are neutralizing anti-GM-CSF autoantibodies present in all healthy persons? (2010) (17)
- EC (European Communities) Workshop on Human Somatic Gene Therapy September 23-24, 1993, Sponsored by the Commission of the European Communities Directorate--General XII for Science, Research and Development (1994) (17)
- A two-site sandwich immunoradiometric assay of human lymphotoxin with monoclonal antibodies and its applications. (1987) (17)
- Effect of IFNbeta and anti-IFNbeta antibodies on NK cells in multiple sclerosis patients. (2000) (16)
- IL-4 acts as a homeostatic regulator of IL-2-induced TNF and IFN-gamma. (1991) (16)
- Assays for transforming growth factor beta. (1991) (16)
- Tumour necrosis factor production by alveolar macrophages in pulmonary sarcoidosis and tuberculosis. (1992) (15)
- Bioimmunoassays for proinflammatory cytokines involving cytokine-induced cellular adhesion molecule expression in human glioblastoma cell lines. (1996) (15)
- Production and screening of cell hybrids producing a monoclonal antibody to human interferon-alpha. (1981) (15)
- Detection of anti-cytokine antibodies and their clinical relevance (2014) (14)
- Mechanism of suppression of normal hemopoietic activity by lymphokine-activated killer cells and their products. (1991) (13)
- Development of resistance to tumour necrosis factor (TNF alpha) in KYM-1 cells involves both TNF receptors. (1993) (13)
- Detection of neutralizing interleukin-17 antibodies in autoimmune polyendocrinopathy syndrome-1 (APS-1) patients using a novel non-cell based electrochemiluminescence assay. (2010) (13)
- Studies on the structural basis of the RNA polymerase activity of newcastle disease virus particles. (1973) (13)
- Interferon production: variation in yields from human cell lines (1979) (12)
- Interferon standardization and designations. (1997) (12)
- Natural autoantibodies to interferons. (1997) (12)
- Tumour necrosis factor in bronchopulmonary secretion of patients with adult respiratory distress syndrome (1989) (12)
- Antibodies to synthetic polypeptides corresponding to hydrophilic regions of human interferon gamma. (1985) (11)
- A cytotoxicity assay for tumour necrosis factor using a human rhabdomyosarcoma cell line. (1991) (11)
- Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432. (1986) (11)
- Interferon production by human-mouse hybrid cells: dominant mouse control of superinduction and priming. (1980) (11)
- Relative increase of inflammatory CD4+ T cells in the cerebrospinal fluid of multiple sclerosis patients and control individuals (1990) (10)
- Aire-Deficient C 57 BL / 6 Mice Mimicking the Common Human 13-Base Pair Deletion Mutation Present with Only a Mild Autoimmune Phenotype 1 (2009) (10)
- Protein kinase C-dependent phosphorylation is involved in resistance to tumour necrosis factor-alpha-induced cytotoxicity in a human monocytoid cell line. (1993) (10)
- The effect of hypertonic salt on interferon and interferon mRNA synthesis in human MG63 cells. (1982) (10)
- Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples. (2013) (10)
- An anti-cytokine bioactivity assay for interferons-α, -β and -ω (1996) (9)
- Stimulation of interferon yields from cultured human cells by calcium salts (1978) (9)
- Epitope localization of a monoclonal antibody, LO-22, with broad specificity for interferon-alpha subtypes. (1986) (9)
- Characterization and partial purification of a novel cytotoxic lymphokine (factor 2) produced by a human B cell line (Karpas 160). (1992) (9)
- Human antibodies to insulin in diabetes. (1994) (9)
- Localization of alpha-interferon in the human feto-placental unit. (1988) (8)
- The biological properties, assay, and standardization of interferon-alpha: a need for a WHO collaborative study. (1996) (8)
- Viral Inhibitors and Immune Response Mediators: The Interferons (2006) (8)
- An Overview of Cytokine Regulation of Inflammation and Immunity (2013) (8)
- Raised levels of tumor-necrosis factor alpha (TNFα) in cardiac transplant patients (1993) (8)
- Hepatic expression of interferon-α in chronic hepatitis B virus infection (1994) (7)
- Antigenic characteristics of glycosylated natural and unglycosylated recombinant human gamma-interferon. (1986) (7)
- A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells. (2008) (7)
- International collaborative study of the candidate international standards for human tumour necrosis factors alpha (hTNF-α) and beta (hTNF-β) and for murine tumour necrosis factor alpha (mTNF-α) (1994) (7)
- Human somatic gene therapy. (1994) (7)
- Thermal stability of the WHO international standard of interferon alpha 2b (IFN-α2b): Application of new reporter gene assay for IFN-α2b potency determinations (2007) (7)
- Gene therapy technologies, applications and regulations : from laboratory to clinic (1999) (7)
- Spontaneous production of gamma interferon and induced production of beta interferon by human T-lymphoblastoid cell lines (1982) (7)
- Quantification of a pegylated interferon-alpha2a product by a customised and validated reverse phase-high performance liquid chromatography method. (2013) (6)
- Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokines. (1997) (6)
- Seventh WHO informal consultation on standards for cytokines, growth factors and endocrinological substances. (2004) (6)
- Agonistic and Antagonistic Antibodies as a Tool to Study the Functional Role of Human Tumor Necrosis Factor Receptors (1993) (6)
- IL-4 and TNF-alpha-mediated proliferation of the human megakaryocytic line M-O7E is regulated by induced autocrine production of GM-CSF. (1996) (6)
- Expression of the human interferon-β gene cloned in phage M13 mp7 (1983) (6)
- A tumour necrosis factor-alpha (TNF-α) sensitive adherent KYM-1D4 derived cell line : Use in TNF-α cytotoxicity assays in the presence of actinomycin D (1999) (5)
- Hepatic interferon-alpha gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection. (1991) (5)
- Ricin-resistant human T-cell hybridomas producing interferon gamma. (1985) (5)
- Production ofinterferon-gamma andtumour necrosis factor-alpha by humanT-cell clones expressing different formsoftheybreceptor (1990) (5)
- Tumor necrosis factor (TNF)-induced protein phosphorylation in a human rhabdomyosarcoma cell line is mediated by 60-kD TNF receptors (TR60). (1994) (4)
- An anti-cytokine bioactivity assay for interferons-alpha, -beta and -omega. (1996) (4)
- Standardization of human IL-29 (IFN-λ1): establishment of a World Health Organization international reference reagent for IL-29 (IFN-λ1). (2014) (4)
- Cell‐Based Assays for the Detection of Neutralizing Antibodies to Interferon Beta (IFN‐β) and Tumor Necrosis Factor Alpha (TNF‐α) Inhibitors (2011) (3)
- Aicardi–Goutières syndrome presenting with haematemesis in infancy (2009) (3)
- Comment on “Aberrant type 1 immunity drives susceptibility to mucosal fungal infections” (2021) (3)
- Evaluation of activity, aggregation and NAB testing with generic interferon beta products: implications for treating multiple sclerosis (2008) (2)
- Modulation of anti-tumor cytotoxicity of cultured mast cells by metabolic inhibitors. (1992) (2)
- Interferon gamma produced by mitogen‐activated T lymphocytes does not directly mediate lymphoproliferation (1985) (2)
- Assays for cytotoxicity. (2004) (2)
- Fourth International Congress on Tumour Necrosis Factor and Related Cytokines. Meeting at Koningshof, Veldhoven, The Netherlands 2-6 May 1992. (1992) (2)
- The interferons: Past, present and future (2009) (2)
- GENETIC CONTROL OF INTERFERON FORMATION (1980) (2)
- INTERFERON-α PRIMES EARLY PROLIFERATIVE RESPONSE OF BONE MARROW CELLS IN VIVO (1998) (2)
- Improvement of potential therapeutic value of tumor necrosis-α (TNF-α) by charge modulation in the tip region (2005) (2)
- Production of TNF α and IL-1β in association with clearance of hepatitis B virus in interferon treated carriers (1989) (1)
- Development of interferon-specific monoclonal antibody for in vitro interferon assays. (1986) (1)
- Gene Transfer Vectors for Clinical Applications (2007) (1)
- Biological standardization of cytokines. (1988) (1)
- International collaborative study of the candidate international standards for human tumour necrosis factors alpha (hTNF-alpha) and beta (hTNF-beta) and for murine tumour necrosis factor alpha (mTNF-alpha). (1994) (1)
- The Development of the Regulatory Process in Europe for Biological Medicines: How it Affects Gene Therapy Products (2001) (1)
- EC workshop on human somatic gene therapy. Commission of the European Communities Directorate--General XII for Science, Research and Development, 23-24 September 1993. (1994) (1)
- Biological Standardization of Interferons and Other Cytokines (2008) (1)
- Lymphotoxin and Class II HLA-DR Co-Precipitate? (1989) (1)
- Clonal analysis of the relationship between class II MHC-restricted cytolysis and lymphokine secretion in murine L3T4+ T cells. (1991) (1)
- Improvement of potential therapeutic value of tumor necrosis-alpha (TNF-alpha) by charge modulation in the tip region. (2005) (1)
- Short communication Effect of IFNb and anti-IFNb antibodies on NK cells in multiple sclerosis patients (2000) (1)
- Expression of the human interferon-beta gene cloned in phage M13 mp7. (1983) (0)
- Immunoassays for human tumour necrosis factors alpha and beta (1988) (0)
- TNF-α Signal Transduction Involves Distinct Phosphorylation Events in U937 Histiocytic Cells (1991) (0)
- A tumour necrosis factor-alpha (TNF-alpha) sensitive adherent KYM-1D4 derived cell line: use in TNF-alpha cytotoxicity assays in the presence of actinomycin D. (1999) (0)
- Synthetic peptides as an analytical tool for studying ligand-acceptor binding (1992) (0)
- Tnf alpha mediated cytolysis in human kym 1 cells is mediated by p60 tnf receptors (1991) (0)
- Measurement of neutralising antibodies to human interferon-[beta] by quantitative analysis of type 1 interferon inducible 6-16 mRNA (2008) (0)
- Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1. (2023) (0)
- Haematopoietic Growth Factors in Clinical Applications (1991) (0)
- Transcripts in Their Tumors Patients with Thymomas and Autoantigen Clinical and Serologic Parallels to APS-I in (2014) (0)
- Quality assurance of biologics and conclusions to be drawn for gene therapy products (1997) (0)
- Report on a collaborative study for proposed 1 st WHO reference reagent for human interleukin-29 (IL-29) (2012) (0)
- Book reviewInterferom and Nonviral pathogens: Byrne, G.I. and Turco, J. (Eds.), vii + 317 pp. Marcell Dekker, New York 1988. $ 119.50, ISBN 0-824-77973-8 (1989) (0)
- Factors involved in the producton of interferon by inactivated Newcastle disease virus. (1972) (0)
- Cytokine Interactions and Their Control (1992) (0)
- Tumor necrosis factor in tulminant hepatic failure (1990) (0)
- Production of human alpha- and beta- interferons by human-rodent hybrids. (1982) (0)
- EC workshop on human somatic gene therapy editorial note (1995) (0)
- 5th International Congress on Tumour Necrosis Factor and Related Cytokines: Scientific Advances and their Medical Applications. (1994) (0)
- J. P. Lecocq Conference on gene therapy. 5-7 July 1994 Ecole Superieure de Biotechnologie de Strasbourg, Pole API, Parc d'Innovation, Illkirch, Nr Strasbourg, France. (1995) (0)
- Anti-Cytokine Autoantibodies Preceding Onset of Autoimmune Polyendocrine Syndrome Type I Features in Early Childhood (2013) (0)
- Radioligand-Binding Assay Reveals Distinct Autoantibody Preferences for Type I Interferons in APS I and Myasthenia Gravis Subgroups (2011) (0)
- Interferon alpha primes early proliferative response of bone marrow cells in vivo. (1998) (0)
- Studies on the replication and functions of Newcastle disease virus ribonucleic acids (1972) (0)
- Human Cytokine Standards and Reference Reagents (2000) (0)
- Standardization of human IFN gamma in comparison with other interferons. (1986) (0)
- Therapeutic efficacy of interferon-beta in a xenograft model of acute myeloid leukaemia (2006) (0)
- Mutation Present with Only a Mild Common Human 13-Base Pair Deletion Aire-Deficient C57BL/6 Mice Mimicking the (2013) (0)
- The year in immunology 1988, vol. 5: Immunoregulatory cytokines and cell growth: Cruse, J.M. and Lewis, Jr., R.E. (Eds.) Karger, Basel, 1989. £ 90.00, ISBN 8055-4895-8 (1989) (0)
- Standardization of Human IL-29 (IFN- l 1): Establishment of a World Health Organization International Reference Reagent for IL-29 (IFN- l 1) Participants of the Collaborative Study (2014) (0)
- Interferons and other regulatory cytokines: De Maeyer, E. and De Maeyer-Guignard, J., 448 pp. John Wiley, New York, 1988. £ 62.50, ISBN 0-471-82887-4 (1989) (0)
- Originals Reduction of tumor necrosis factor 9 and interleukin-lfl levels in human synovial tissue by interleukin-4 and glucocorticoid (0)
- Human cell lines used for interferon production survey ' INFECT . IMMUN (0)
- Effect ofcyclo-oxygenase inhibitors andmodulators ofcyclic AMP formation on lipopolysacchari de-induced neutrophil infiltration inmouse lung (1996) (0)
- National Institute for Biological Standards and Control. Human cytokine standards and reference reagents. (2000) (0)
- The Role of Lymphotoxin in the Pathogenesis of Celiac Disease (1989) (0)
- Evidence for a role of IFN γ in control ofListeria monocytogenes in T cell deficient mice (1991) (0)
- Thermal stability of the WHO international standard of interferon alpha 2b (IFN-alpha 2b): application of new reporter gene assay for IFN-alpha 2b potency determinations. (2007) (0)
- Stabilisation of cytokine solutions by casein (2001) (0)
- Cell Lines and Primary Tissues for In‐Vitro Evaluation of Vaccine Efficacy (2006) (0)
- Blockade of cytokine activity by soluble cytokine receptors (2000) (0)
- INDUCTION OF IMMUNE INTERFERON FROM HUMAN LYMPHOCYTES BY INFLUENZA-INFECTED STIMULATOR CELLS (1982) (0)
This paper list is powered by the following services: